211 related articles for article (PubMed ID: 31227599)
1. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
[TBL] [Abstract][Full Text] [Related]
2. Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.
Ma W; Chen LS; Özbek U; Han SW; Lin C; Paulovich AG; Zhong H; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S66-S81. PubMed ID: 31281117
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
4. Characterizing functional consequences of DNA copy number alterations in breast and ovarian tumors by spaceMap.
Conley CJ; Ozbek U; Wang P; Peng J
J Genet Genomics; 2018 Jul; 45(7):361-371. PubMed ID: 30057342
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.
Zhang Y; Chen F; Chandrashekar DS; Varambally S; Creighton CJ
Nat Commun; 2022 May; 13(1):2669. PubMed ID: 35562349
[TBL] [Abstract][Full Text] [Related]
6. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
7. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
[TBL] [Abstract][Full Text] [Related]
8. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
10. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
11. Tensor GSVD of patient- and platform-matched tumor and normal DNA copy-number profiles uncovers chromosome arm-wide patterns of tumor-exclusive platform-consistent alterations encoding for cell transformation and predicting ovarian cancer survival.
Sankaranarayanan P; Schomay TE; Aiello KA; Alter O
PLoS One; 2015; 10(4):e0121396. PubMed ID: 25875127
[TBL] [Abstract][Full Text] [Related]
12. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
Chung RH; Kang CY
Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
[TBL] [Abstract][Full Text] [Related]
13. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.
Jamalzadeh S; Dai J; Lavikka K; Li Y; Jiang J; Huhtinen K; Virtanen A; Oikkonen J; Hietanen S; Hynninen J; Vähärautio A; Häkkinen A; Hautaniemi S
BMC Cancer; 2024 Feb; 24(1):173. PubMed ID: 38317080
[TBL] [Abstract][Full Text] [Related]
15. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
[TBL] [Abstract][Full Text] [Related]
16. MMDAE-HGSOC: A novel method for high-grade serous ovarian cancer molecular subtypes classification based on multi-modal deep autoencoder.
Wang HQ; Li HL; Han JL; Feng ZP; Deng HX; Han X
Comput Biol Chem; 2023 Aug; 105():107906. PubMed ID: 37336028
[TBL] [Abstract][Full Text] [Related]
17. Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.
Huang T; Yang J; Cai YD
Biomed Res Int; 2015; 2015():358125. PubMed ID: 25802847
[TBL] [Abstract][Full Text] [Related]
18. Integrative network analysis of TCGA data for ovarian cancer.
Zhang Q; Burdette JE; Wang JP
BMC Syst Biol; 2014 Dec; 8():1338. PubMed ID: 25551281
[TBL] [Abstract][Full Text] [Related]
19. Integrative epigenetic and genetic pan-cancer somatic alteration portraits.
Salas LA; Johnson KC; Koestler DC; O'Sullivan DE; Christensen BC
Epigenetics; 2017 Jul; 12(7):561-574. PubMed ID: 28426276
[TBL] [Abstract][Full Text] [Related]
20. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
